{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:05:31Z","timestamp":1792206331479,"version":"4.4.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Environment International"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.envint.2020.106204","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T07:11:28Z","timestamp":1603782688000},"page":"106204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":181,"special_numbering":"C","title":["Hexafluoropropylene oxide-dimer acid (HFPO-DA or GenX) alters maternal and fetal glucose and lipid metabolism and produces neonatal mortality, low birthweight, and hepatomegaly in the Sprague-Dawley rat"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6622-5769","authenticated-orcid":false,"given":"Justin M.","family":"Conley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy S.","family":"Lambright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9558-3514","authenticated-orcid":false,"given":"Nicola","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"McCord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Strynar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5543-9262","authenticated-orcid":false,"given":"Elizabeth","family":"Medlock-Kakaley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vickie S.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"L. Earl","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.envint.2020.106204_b0005","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/toxsci\/kfm110","article-title":"Perfluorooctanoic acid induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator activated receptor-alpha","volume":"98","author":"Abbott","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.envint.2020.106204_b0010","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.reprotox.2008.05.061","article-title":"Developmental toxicity of perfluorooctane sulfonate (PFOS) is not dependent on expression of peroxisome proliferator activated receptor-alpha (PPAR alpha) in the mouse","volume":"27","author":"Abbott","year":"2009","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.envint.2020.106204_b0015","series-title":"Toxicological Effects of Perfluoroalkyl and Polyfluoroalkyl substances","first-page":"203","article-title":"Developmental Toxicity","author":"Abbott","year":"2015"},{"key":"10.1016\/j.envint.2020.106204_b0020","unstructured":"ATSDR, 2018. Toxicological Profile for Perfluoroalkyls: Draft for Public Comment June 2018. US Department of Health and Human Services CS274127-A."},{"key":"10.1016\/j.envint.2020.106204_b0025","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/10408444.2014.952400","article-title":"Perfluoroalkyl and polyfluoroalkyl substances and human fetal growth: a systematic review","volume":"45","author":"Bach","year":"2015","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.envint.2020.106204_b0030","unstructured":"Beekman, M., Zweers, P., Muller, A., de Vries, W., Janssen, P., Zeilmaker, M., 2016. Evaluation of substances used in the GenX technology by Chemours, Dordrecht. National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport:Netherlands."},{"key":"10.1016\/j.envint.2020.106204_b0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.tox.2017.03.012","article-title":"The margin of internal exposure (MOIE) concept for dermal risk assessment based on oral toxicity data - A case study with caffeine","volume":"392","author":"Bessems","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/j.envint.2020.106204_b0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tox.2011.06.012","article-title":"Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes","volume":"288","author":"Bjork","year":"2011","journal-title":"Toxicology"},{"key":"10.1016\/j.envint.2020.106204_b0045","doi-asserted-by":"crossref","first-page":"27006","DOI":"10.1289\/EHP6233","article-title":"Evaluation of Maternal, Embryo, and Placental Effects in CD-1 Mice following Gestational Exposure to Perfluorooctanoic Acid (PFOA) or Hexafluoropropylene Oxide Dimer Acid (HFPO-DA or GenX)","volume":"128","author":"Blake","year":"2020","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.envint.2020.106204_b0050","doi-asserted-by":"crossref","first-page":"R920","DOI":"10.1152\/ajpregu.00197.2015","article-title":"Limited capacity for glucose oxidation in fetal sheep with intrauterine growth restriction","volume":"309","author":"Brown","year":"2015","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.envint.2020.106204_b0055","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tox.2003.11.005","article-title":"The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat","volume":"196","author":"Butenhoff","year":"2004","journal-title":"Toxicology"},{"key":"10.1016\/j.envint.2020.106204_b0060","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.2337\/dc18-2254","article-title":"Associations of perfluoroalkyl and polyfluoroalkyl substances with incident diabetes and microvascular disease","volume":"42","author":"Cardenas","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.envint.2020.106204_b0065","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.toxrep.2015.06.001","article-title":"Evaluation of chronic toxicity and carcinogenicity of ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate in Sprague-Dawley rats","volume":"2","author":"Caverly Rae","year":"2015","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.envint.2020.106204_b0070","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.reprotox.2011.07.002","article-title":"Comparative pharmacokinetics of perfluorooctanesulfonate (PFOS) in rats, mice, and monkeys","volume":"33","author":"Chang","year":"2012","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.envint.2020.106204_b0075","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.reprotox.2011.03.003","article-title":"Prenatal PFOS exposure induces oxidative stress and apoptosis in the lung of rat off-spring","volume":"33","author":"Chen","year":"2012","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.envint.2020.106204_b0080","doi-asserted-by":"crossref","first-page":"37008","DOI":"10.1289\/EHP4372","article-title":"Adverse maternal, fetal, and postnatal effects of hexafluoropropylene oxide dimer acid (GenX) from oral gestational exposure in sprague-dawley rats","volume":"127","author":"Conley","year":"2019","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.envint.2020.106204_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408444.2013.835784","article-title":"Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPARalpha) as a case study","volume":"44","author":"Corton","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.envint.2020.106204_b0090","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00204-017-2094-7","article-title":"The PPARalpha-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions","volume":"92","author":"Corton","year":"2018","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.envint.2020.106204_b0095","unstructured":"Ditzenberger, G.R., 2018. Carbohydrate, Fat, and Protein Metabolism. In: Maternal, Fetal, & Neonatal Physiology: A Clinical Perspective 5th Editions, (Blackburn ST, ed). St. Louis, MO:Elsevier, 543-570."},{"key":"10.1016\/j.envint.2020.106204_b0100","unstructured":"DuPont, 2008a. DuPont-24447: A 28-day oral (gavage) toxicity study of H-28397 in rats with a 28-day recovery. Study #WIL-189205. OECD Guideline 407. Conducted by WIL Research Laboratories, LLC. EI du Pont de Nemours and Company 1-4. USEPA HERO ID: 4221045-4221050."},{"key":"10.1016\/j.envint.2020.106204_b0105","unstructured":"DuPont, 2008b. DuPont-24459: A 28-day oral (gavage) toxicity study of H-28397 in mice with a 28-day recovery. Study #WIL-189205. OECD Guideline 407. Conducted by WIL Research Laboratories, LLC. EI du Pont de Nemours and Company 1-4. USEPA HERO ID: 4221051-4221054."},{"key":"10.1016\/j.envint.2020.106204_b0110","unstructured":"DuPont, 2010a. DuPont-18405-841: An oral (gavage) prenatal developmental toxicity study of H-28548 in rats. OECD Guideline 414. EI du Pont de Nemours and Company USEPA HERO ID: 4222145."},{"key":"10.1016\/j.envint.2020.106204_b0115","unstructured":"DuPont, 2010b. DuPont-18405-1037: An oral (gavage) reproduction\/developmental toxicity screening study of H-28548 in mice. EI du Pont de Nemours and Company USEPA HERO ID: 4222148."},{"key":"10.1016\/j.envint.2020.106204_b0120","unstructured":"DuPont, 2010c. DuPont GenX Processing Aid for Making Fluoropolymer Resins: Setting a New Industry Standard for Sustainable Replacement Technology. https:\/\/bladenonlinecom\/wp-content\/uploads\/2017\/06\/Chemours_GenX_Brochure_Final_07July2010pdf Accessed 13 June 2018."},{"key":"10.1016\/j.envint.2020.106204_b0125","unstructured":"DuPont, 2017. DuPont-C30031_516655: Determination of HFPO-DA in EDTA human plasma samples. Charles River Laboratories. The Chemours Company USEPA HERO ID: 4353920."},{"key":"10.1016\/j.envint.2020.106204_b0130","unstructured":"ECHA, 2014. Annex XV Restriction Report: Proposal for Restriction - Perfluorooctanoic acid (PFOA), PFOA salts and PFOA-related substances."},{"key":"10.1016\/j.envint.2020.106204_b0135","unstructured":"Evans, N., Cardon, M., Hartig, P., Medlock Kakaley, E., Wilson, V.S., Conley, J.M., et al. 2020. In vitro binding of human and rat PPAR alpha, beta\/delta, and gamma receptors to PFAS, fatty acids, and clofibric acid. The Toxicologist: Supplement to Toxicological Sciences 174."},{"key":"10.1016\/j.envint.2020.106204_b0140","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.coph.2006.06.009","article-title":"PPARalpha and PPARgamma dual agonists for the treatment of type 2 diabetes and the metabolic syndrome","volume":"6","author":"Fievet","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.envint.2020.106204_b0145","doi-asserted-by":"crossref","first-page":"7175","DOI":"10.1021\/acs.est.9b07384","article-title":"Evidence of Air Dispersion: HFPO-DA and PFOA in Ohio and West Virginia Surface Water and Soil near a Fluoropolymer Production Facility","volume":"54","author":"Galloway","year":"2020","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.envint.2020.106204_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2015.12.006","article-title":"Absorption, distribution, metabolism, excretion, and kinetics of 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propanoic acid ammonium salt following a single dose in rat, mouse, and cynomolgus monkey","volume":"340","author":"Gannon","year":"2016","journal-title":"Toxicology"},{"key":"10.1016\/j.envint.2020.106204_b0155","doi-asserted-by":"crossref","first-page":"11057","DOI":"10.1021\/acs.est.7b02488","article-title":"Presence of Emerging Per- and Polyfluoroalkyl Substances (PFASs) in River and Drinking Water near a Fluorochemical Production Plant in the Netherlands","volume":"51","author":"Gebbink","year":"2017","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.envint.2020.106204_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.envint.2018.01.011","article-title":"Comparing the toxic potency in vivo of long-chain perfluoroalkyl acids and fluorinated alternatives","volume":"113","author":"Gomis","year":"2018","journal-title":"Environ. Int."},{"key":"10.1016\/j.envint.2020.106204_b0165","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/bdrb.10046","article-title":"Prenatal window of susceptibility to perfluorooctane sulfonate-induced neonatal mortality in the Sprague-Dawley rat","volume":"68","author":"Grasty","year":"2003","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.envint.2020.106204_b0170","first-page":"999","article-title":"PPAR gamma in human and mouse physiology","volume":"1771","author":"Heikkinen","year":"2007","journal-title":"BBA"},{"key":"10.1016\/j.envint.2020.106204_b0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082189","article-title":"The opportunities and challenges of peroxisome proliferator-activated receptors ligands in clinical drug discovery and development","volume":"19","author":"Hong","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.envint.2020.106204_b0180","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1186\/s12864-015-1969-3","article-title":"The impact of PPARalpha activation on whole genome gene expression in human precision cut liver slices","volume":"16","author":"Janssen","year":"2015","journal-title":"BMC Genom."},{"key":"10.1016\/j.envint.2020.106204_b0185","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI6223","article-title":"Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting","volume":"103","author":"Kersten","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.envint.2020.106204_b0190","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.molmet.2014.02.002","article-title":"Integrated physiology and systems biology of PPARalpha","volume":"3","author":"Kersten","year":"2014","journal-title":"Mol. Metab."},{"key":"10.1016\/j.envint.2020.106204_b0195","doi-asserted-by":"crossref","DOI":"10.1038\/gim.2014.128","article-title":"Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics","volume":"16","author":"Kishnani","year":"2014","journal-title":"Genet. Med."},{"key":"10.1016\/j.envint.2020.106204_b0200","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1093\/jn\/116.10.1922","article-title":"Effect of low carbohydrate diets during pregnancy on embryogenesis and fetal growth and development in rats","volume":"116","author":"Koski","year":"1986","journal-title":"J. Nutr."},{"key":"10.1016\/j.envint.2020.106204_b0205","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/jn\/120.9.1016","article-title":"Evidence for a critical period during late gestation when maternal dietary carbohydrate is essential for survival of newborn rats","volume":"120","author":"Koski","year":"1990","journal-title":"J. Nutr."},{"key":"10.1016\/j.envint.2020.106204_b0210","article-title":"Measurement of novel, drinking water-associated PFAS in blood from adults and children in Wilmington, North Carolina","volume":"128","author":"Kotlarz","year":"2020","journal-title":"Environ. Health Perspect."},{"issue":"4","key":"10.1016\/j.envint.2020.106204_b0215","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/jn\/129.4.820","article-title":"Postnatal profiles of glycogenolysis and gluconeogenesis are modified in rat pups by maternal dietary glucose restriction","volume":"129","author":"Lanoue","year":"1999","journal-title":"J. Nutr."},{"key":"10.1016\/j.envint.2020.106204_b0220","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/toxsci\/kfg122","article-title":"Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation","volume":"74","author":"Lau","year":"2003","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.envint.2020.106204_b0225","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/toxsci\/kfm128","article-title":"Perfluoroalkyl acids: a review of monitoring and toxicological findings","volume":"99","author":"Lau","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.envint.2020.106204_b0230","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.fct.2003.08.011","article-title":"Toxicity and carcinogenicity of acidogenic or alkalogenic diets in rats; effects of feeding NH(4)Cl, KHCO(3) or KCl","volume":"42","author":"Lina","year":"2004","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.envint.2020.106204_b0235","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.tox.2005.07.018","article-title":"Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats","volume":"215","author":"Luebker","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.envint.2020.106204_b0240","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.tox.2005.07.019","article-title":"Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters","volume":"215","author":"Luebker","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.envint.2020.106204_b0245","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2796.2007.01800.x","article-title":"Experimental IUGR and later diabetes","volume":"261","author":"Martin-Gronert","year":"2007","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.envint.2020.106204_b0250","first-page":"1","article-title":"Births: Final Data for 2018","volume":"68","author":"Martin","year":"2019","journal-title":"Natl. Vital Statistics Reports"},{"key":"10.1016\/j.envint.2020.106204_b0255","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.chroma.2018.03.047","article-title":"Validation of quantitative measurements and semi-quantitative estimates of emerging perfluoroethercarboxylic acids (PFECAs) and hexfluoroprolyene oxide acids (HFPOAs)","volume":"1551","author":"McCord","year":"2018","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.envint.2020.106204_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2020.105935","article-title":"Prenatal exposure to perfluoroalkyl substances modulates neonatal serum phospholipids, increasing risk of type 1 diabetes","volume":"143","author":"McGlinchey","year":"2020","journal-title":"Environ. Int."},{"key":"10.1016\/j.envint.2020.106204_b0265","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1056\/NEJM199904223401603","article-title":"Birth weight in relation to morbidity and mortality among newborn infants","volume":"340","author":"McIntire","year":"1999","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.envint.2020.106204_b0270","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1080\/10408444.2016.1271972","article-title":"Exposure to PFOA and PFOS and fetal growth: a critical merging of toxicological and epidemiological data","volume":"47","author":"Negri","year":"2017","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.envint.2020.106204_b0275","unstructured":"NHMRC N. 2011. Australian Drinking Water Guidelines Paper 6 National Water Quality Management Strategy. National Health and Medical Research Council, National Resource Management Ministerial Council, Commonwealth of Australia."},{"key":"10.1016\/j.envint.2020.106204_b0280","unstructured":"OECD, 2002. Hazard Assessment of Perfluorooctane Sulfonate (PFOS) and its salts. ENV\/JM\/RD(2002)17\/FINAL."},{"key":"10.1016\/j.envint.2020.106204_b0285","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1289\/ehp.10009","article-title":"Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers","volume":"115","author":"Olsen","year":"2007","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.envint.2020.106204_b0290","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1124\/mol.53.1.14","article-title":"Peroxisome proliferator activated receptor alpha expression in human liver","volume":"53","author":"Palmer","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.envint.2020.106204_b0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006796","article-title":"Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human","volume":"4","author":"Rakhshandehroo","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.envint.2020.106204_b0300","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tox.2017.05.013","article-title":"PPARalpha-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling","volume":"387","author":"Rosen","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/j.envint.2020.106204_b0305","first-page":"179","article-title":"Evaluation of the immunomodulatory effects of 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate in C57BL\/6 mice","volume":"156","author":"Rushing","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.envint.2020.106204_b0310","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/bmj.1.5378.273","article-title":"Carbohydrate reserves in the newborn infant","volume":"1","author":"Shelley","year":"1964","journal-title":"Brit. Med. J."},{"key":"10.1016\/j.envint.2020.106204_b0315","doi-asserted-by":"crossref","first-page":"11622","DOI":"10.1021\/acs.est.5b01215","article-title":"Identification of Novel Perfluoroalkyl Ether Carboxylic Acids (PFECAs) and Sulfonic Acids (PFESAs) in Natural Waters Using Accurate Mass Time-of-Flight Mass Spectrometry (TOFMS)","volume":"49","author":"Strynar","year":"2015","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.envint.2020.106204_b0320","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1021\/acs.estlett.6b00398","article-title":"Legacy and emerging perfluoroalkyl substances are important drinking water contaminants in the cape fear river watershed of North Carolina","volume":"3","author":"Sun","year":"2016","journal-title":"Environ. Sci. Technol. Lett."},{"key":"10.1016\/j.envint.2020.106204_b0325","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrendo.2009.195","article-title":"Nutritional programming of the metabolic syndrome","volume":"5","author":"Symonds","year":"2009","journal-title":"Nature Rev Endocrinol"},{"key":"10.1016\/j.envint.2020.106204_b0330","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/toxsci\/kfg121","article-title":"Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations","volume":"74","author":"Thibodeaux","year":"2003","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.envint.2020.106204_b0335","unstructured":"USEPA-HERO, 2018. Health & Environmental Research Online: GenX (13252-13-6). Online available - Accessed July 25, 2018 https:\/\/hero.epa.gov\/hero\/index.cfm\/project\/page\/project_id\/2627."},{"key":"10.1016\/j.envint.2020.106204_b0340","unstructured":"USEPA, 2016a. Health Effects Support Document for Perfluorooctane Sulfonate (PFOS). EPA Publication No EPA 822-R-16-002."},{"key":"10.1016\/j.envint.2020.106204_b0345","unstructured":"USEPA, 2016b. Drinking water health advisory for perfluorooctane sulfonate (PFOS). EPA 822-R-16-004."},{"key":"10.1016\/j.envint.2020.106204_b0350","unstructured":"USEPA, 2016c. Drinking water health advisory for perfluorooctanoic acid (PFOA). EPA 822-R-16-005."},{"key":"10.1016\/j.envint.2020.106204_b0355","unstructured":"USEPA, 2018. Human health toxicity values for hexafluoropropylene oxide (HFPO) dimer acid and its ammonium salt (CASRN 13252-13-6 and CASRN 62037-89-3): Also known as \u201cGenX Chemicals\u201d. EPA-823-P-18-001 Public Comment Draft."},{"key":"10.1016\/j.envint.2020.106204_b0360","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/toxsci\/kfl014","volume":"92","author":"Vanden Heuvel","year":"2006","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.envint.2020.106204_b0365","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/toxsci\/kfm193","article-title":"Nonclinical safety evaluation of muraglitazar, a novel PPARalpha\/gamma agonist","volume":"100","author":"Waites","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.envint.2020.106204_b0370","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/jat.3376","article-title":"RNA-sequencing analysis reveals the hepatotoxic mechanism of perfluoroalkyl alternatives, HFPO2 and HFPO4, following exposure in mice","volume":"37","author":"Wang","year":"2017","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.envint.2020.106204_b0375","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.mce.2015.12.016","article-title":"Role of placental insufficiency and intrauterine growth restriction on the activation of fetal hepatic glucose production","volume":"435","author":"Wesolowski","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.envint.2020.106204_b0380","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.taap.2017.09.019","article-title":"Perfluorooctanoic acid exposure disturbs glucose metabolism in mouse liver","volume":"335","author":"Zheng","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."}],"container-title":["Environment International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0160412020321590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0160412020321590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T12:00:31Z","timestamp":1758974431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0160412020321590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":76,"alternative-id":["S0160412020321590"],"URL":"https:\/\/doi.org\/10.1016\/j.envint.2020.106204","relation":{},"ISSN":["0160-4120"],"issn-type":[{"value":"0160-4120","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hexafluoropropylene oxide-dimer acid (HFPO-DA or GenX) alters maternal and fetal glucose and lipid metabolism and produces neonatal mortality, low birthweight, and hepatomegaly in the Sprague-Dawley rat","name":"articletitle","label":"Article Title"},{"value":"Environment International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.envint.2020.106204","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106204"}}